JOHNSON KENNETH ERLAND (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001867096-25-000013
Officer· See Remarks
Since Oct 2021
-12.40K
Net shares
Net seller
$44.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
12.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.40K
Price / share
$3.61
Trade value
$44.77K
% of position
3.3%
1/3/2025
374.17K→361.76K
Total
Net shares
−12.40K
Net value
-$44.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | F · Tax Withholding | −12.40K | $3.61 | $44.77K | 3.3% | 374.17K | 361.76K |
| Total | −12.40K | -$44.77K | ||||||
Derivative Transactions0
No derivative transactions reported